Literature DB >> 17435566

Seizure length in electroconvulsive therapy as a function of age, sex, and treatment number.

Joseph J Rasimas1, Susanna R Stevens, Keith G Rasmussen.   

Abstract

Most electroconvulsive therapy (ECT) research indicates that seizure length does not correlate with clinical efficacy. However, it is common in practice for clinicians to undertake measures to prolong seizures if the duration seems to be too short, although there is no universally agreed upon minimum seizure duration for ECT. We felt it would be informative for the ECT field to report mean seizure durations over the course of treatments based on age and sex in a very large cohort to provide norms for reference. We studied 519 patients' courses of ECT and recorded treatment number, sex, and age along with motor and electroencephalogram seizure duration. We found that women have longer seizures, but only at the first treatment session. There is a strong inverse correlation between age and seizure length. The biggest drop in seizure duration along a course of treatments occurs between the first and second treatments; beyond that, seizure duration remains relatively constant.

Entities:  

Mesh:

Year:  2007        PMID: 17435566     DOI: 10.1097/01.yct.0000263254.21668.f0

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  12 in total

1.  Individualized Low-Amplitude Seizure Therapy: Minimizing Current for Electroconvulsive Therapy and Magnetic Seizure Therapy.

Authors:  Angel V Peterchev; Andrew D Krystal; Moacyr A Rosa; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2015-04-28       Impact factor: 7.853

2.  A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development.

Authors:  Laura Kranaster; Suna Su Aksay; Jan Malte Bumb; Carolin Hoyer; Christine Jennen-Steinmetz; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-06       Impact factor: 5.270

Review 3.  Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review.

Authors:  Jared L Moreines; Shawn M McClintock; Paul E Holtzheimer
Journal:  Brain Stimul       Date:  2010-02-11       Impact factor: 8.955

4.  A comparison of propofol and thiopentone for electroconvulsive therapy.

Authors:  Alok Kumar; Devendra Kumar Sharma; Raghunandan Mani
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-07

5.  The Clonic Phase of Seizures in Patients Treated with Electroconvulsive Therapy is Related to Age and Stimulus Intensity.

Authors:  Chao-Chih Wang; Ching-Hung Lin; Yao-Chu Chiu; Chih-Chieh Tseng
Journal:  Front Psychiatry       Date:  2013-12-23       Impact factor: 4.157

6.  Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy.

Authors:  Sung Woo Joo; Yeon Ho Joo; Chang Yoon Kim; Jung Sun Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-29       Impact factor: 2.570

7.  Evaluating Factors Affecting the Time Interval Between Propofol Injection and Induction of Electro-convulsion and Relationship Between These Factors and Duration of Convulsion.

Authors:  Alireza Haji Seyed Javadi; Ehsan Najafian; Hamid Kayalha; Ali Akbar Shafikhani
Journal:  Anesth Pain Med       Date:  2021-09-26

8.  Changes in seizure duration during acute course electroconvulsive therapy.

Authors:  James Luccarelli; Thomas H McCoy; Stephen J Seiner; Michael E Henry
Journal:  Brain Stimul       Date:  2021-06-11       Impact factor: 9.184

9.  Seizure duration decreases over a course of bifrontal and not bitemporal electroconvulsive therapy.

Authors:  Hulegar A Abhishekh; Jagadisha Thirthalli; Anusha Hegde; Vivek H Phutane; Channaveerachari N Kumar; Kesavan Muralidharan; Bangalore N Gangadhar
Journal:  Indian J Psychol Med       Date:  2014-01

10.  Intravenous theophylline is the most effective intervention to prolong EEG seizure duration in patients undergoing electroconvulsive therapy.

Authors:  Alexander Tzabazis; Michaela E Wiernik; Jan Wielopolski; Wolfgang Sperling; Harald Ihmsen; Hubert J Schmitt; Tino Münster
Journal:  BMC Anesthesiol       Date:  2017-08-29       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.